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Abstract
Collagen activates mammalian platelets through a complex of the immunoglobulin (Ig) receptor GPVI and the Fc receptor c-
chain, which has an immunoreceptor tyrosine-based activation motif (ITAM). Cross-linking of GPVI mediates activation
through the sequential activation of Src and Syk family kinases and activation of PLCc2. Nucleated thrombocytes in fish are
activated by collagen but lack an ortholog of GPVI. In this study we show that collagen activates trout thrombocytes in
whole blood and under flow conditions through a Src kinase driven pathway. We identify the Ig receptor G6f-like as a
collagen receptor and demonstrate in a cell line assay that it signals through its cytoplasmic ITAM. Using a morpholino for
in vivo knock-down of G6f-like levels in zebrafish, we observed a marked delay or absence of occlusion of the venous and
arterial systems in response to laser injury. Thus, G6f-like is a physiologically relevant collagen receptor in fish thrombocytes
which signals through the same ITAM-based signalling pathway as mammalian GPVI, providing a novel example of
convergent evolution.
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Introduction
Mechanisms for the cessation of bleeding are an important
evolutionary pressure, and complex organisms have all evolved
haemostatic pathways. Studying human haemostatic and throm-
botic disorders are possible due to the similarities between the
pathways in mammals (i.e. mice); however less is known about the
mechanisms in other species.
The mechanism of activation of mammalian platelets by the
extracellular matrix protein collagen has been studied in great
detail. In the high shear environment of the mammalian
circulatory system, platelets are captured on von Willebrand
factor (VWF)-coated collagen fibres through the GPIb-IX-V
complex. Once arrested, the low affinity immunoglobulin (Ig)
receptor, GPVI, binds to collagen and induces robust platelet
activation though an immunoreceptor tyrosine-based activation
motif (ITAM) in its associated Fc receptor c-chain [1]. This is
followed by the release of the powerful secondary agonists, ADP
and thromboxane A2, allowing the recruitment of further platelets
and the subsequent growth of a thrombus.
The use of zebrafish as a model organism for haemostasis and
thrombosis has increased in recent years, even though we know
much less about haemostasis in fish and there are significant
differences to haemostasis in mammals. For example, fish
thrombocytes are nucleated cells and are generally larger than
the small, anucleate platelets of mammalian circulatory systems.
Furthermore, orthologs of several key platelet receptors are absent
in the fish genome, including the collagen receptor, GPVI, and the
C-type lectin receptor, CLEC-2. Despite these differences,
however, fish thrombocytes readily form thrombi in response to
vessel wall injury and are activated by collagen, suggesting the
presence of a novel collagen receptor [2,3,4,5,6,7].
An ITAM has two YxxLs separated by 6–12 amino acids.
Clustering of ITAM receptors such as the collagen receptor GPVI
leads to Src family kinase-dependent phosphorylation of the two
conserved tyrosines and subsequent binding and activation of Syk
tyrosine kinase [1]. This initiates a signalling cascade that
culminates in the activation of PLCc2, which in turn mediates
cellular activation through production of the secondary messen-
gers inositol-1,4,5-trisphosphate (IP3) and 1,2-diacylglycerol
(DAG). Syk is highly conserved throughout evolution and
orthologs have been found in the first vertebrate, the jawless fish,
which date back to the Cambrian era, over 500 million years ago
[8].
We have been unable to identify a functional homologue of
GPVI in non-mammalian vertebrates, including teleost fish. We
therefore hypothesised that collagen activates fish thrombocytes in
a similar pathway to that of mammals but through a novel ITAM
receptor. A candidate for such a receptor is the protein known as
G6f-like (G6fL) which has been shown to be expressed exclusively
on thrombocytes, although interestingly it is also expressed on
erythrocytes in crucian carp [9]. G6fL has four extracellular Ig-like
domains, a single transmembrane domain and a short cytoplasmic
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tail containing a conserved Grb2 binding domain YxN, and an
ITAM [9]. The ITAM is split over two exons, a notable feature of
classical ITAMs.
In the present study we demonstrate that G6fL is a functional
receptor for collagen in thrombocytes in zebrafish, signalling
through a similar pathway to the mammalian collagen receptor
GPVI. This is a novel example of convergent evolution of the
signalling pathway.
Methods
Reagents
Horm collagen was purchased from Nycomed (Munich,
Germany). Human fibrinogen was purchased from Enzyme
Research Laboratories (Swansea, UK). Horseradish-peroxidase-
conjugated a-rabbit secondary antibody, and enhanced chemilu-
minescence reagents were purchased from Amersham Biosciences
(GE Healthcare, Bucks, UK). DT40 cells [10] were provided by
Dr M. Tomlinson (The University of Birmingham, UK). A
polyclonal antibody for G6fL was produced by BioGenes (Berlin,
Germany). Two rabbits were immunised with a peptide
corresponding to residues 203–217 in the extracellular domain
of zebrafish G6fL. Serum was tested by ELISA against the peptide
and subsequently against zebrafish thrombocytes. All other
reagents were purchased from Sigma-Aldrich (Poole, UK) or
from previously described sources [11].
Constructs
Zebrafish RNA was isolated with TRIzol from the anterior
body part and then reverse transcribed into cDNA with random
hexamers using the Superscript First-Strand Synthesis System for
RT-PCR (Invitrogen, Paisley, UK). PCR was performed using
PrimeSTAR HS DNA Polymerase (Takara Bio, Otsu, Japan) with
the primers G6FL-59UTR-FWD (59-CTA-ACT-ATT-AAG-
GAT-ATA-TTG-CTT-CCT-AGA-AGC-ATC-39) and G6FL-
39UTR-REV (59-TGT-CCC-ATT-ATT-TAT-GGA-CCT-
AAC-TGT-AAC-39). PCR fragments were blunt-end cloned into
the HincII site of vector pUC118 and the sequence of individual
clones were determined using CEQ Dye terminator Cycle
Sequencing Kit (Beckman Coulter, High Wycombe, UK) and an
automated sequencer CEQTM2000 DNA Analysis System (Beck-
man Coulter). The clone that was used for further experiment was
a common splicoform identical with GenBank accession
GU393012, except for an extra nucleotide triplet adding an
alanine to the ectodomain stalk region [9].
G6fL was sub-cloned into the pEF6 expression vector using the
following primers G6fL-FWD (59-TAG-TAG-GGT-ACC-ACC-
ATG-AGG-AAA-AAT-GAT-CAA-GCT-TTT-39), G6fL-REV
(59-TAG-TAG-GCG-GCC-GCT-CAA-CCA-CAG-CAC-TGG-
TTG-TAT-CTC-TCC-39). Subsequent mutations were made
using the Quikchange II Site Directed Mutagenesis kit (Agilent
Technologies, Stockport, UK) with the following primers G6fL-
Y499F-FWD (59-CGG-AGA-GGT-GGA-GAA-CAT-CTT-
TGA-AAA-TCC-TGA-TG-39), G6fL-Y499F-REV (59-CAT-
CAG-GAT-TTT-CAA-AGA-TGT-TCT-CCA-CCT-CTC-CG-
39), G6fL-Y515F-FWD (59-CCC-AAG-GCG-CAG-TCT-TCA-
TGG-ATC-TCA-AGC-C-39), G6fL-Y515F-REV (59-GGC-
TTG-AGA-TCC-ATG-AAG-ACT-GCG-CCT-TGG-G-39),
G6fL-Y527F-FWD (59-CCA-ACG-GGT-GAA-ATG-GAT-
GTA-TTT-AAA-GAA-TTG-GAG-AGA-TAC-AAC-39), G6fL-
Y527F-REV (59-GTT-GTA-TCT-CTC-CAA-TTC-TTT-AAA-
TAC-ATC-CAT-TTC-ACC-CGT-TGG-39).
Preparation of Thrombocytes from Trout Blood and
Whole Blood Aggregometry
Blood was drawn from farmed rainbow trout (Hathersage, UK)
in accordance with ‘The Humane Killing of Animals under
Schedule 1 to the Animals (Scientific Procedures) Act 1986’ by
concussion of the brain, into heparin (100 U/ml). Trout blood was
kept on ice until required for study and all experiments were
performed at room temperature. Anticoagulated blood from trout
was diluted 1:1 using normal saline (0.9%) in a mini-cuvette
(Verum Diagnostica, Munich, Germany) and stirred for 3 min at
room temperature. Dasatinib or DMSO vehicle control was pre-
incubated at room temperature for 1 min followed by addition of
collagen. Following agonist addition, aggregation was monitored
at room temperature for 12 min, calculated by impedance across
two electrode pairs (Multiplate analyser, Instrumentation Labora-
tory UK Ltd, Warrington, UK), and reported in arbitrary
impedance units (AU).
Static Adhesion Assay
Coverslips were coated with matrix proteins as previously
reported [12] followed by blocking with 5 mg/ml of heat-
inactivated bovine serum albumin (BSA) in PBS for 1 hr at room
temperature. Trout thrombocytes were allowed to spread for
90 min at room temperature, before washing with PBS followed
by fixation with paraformaldehyde (3.7%). Thrombocytes were
imaged by DIC microscopy on a Zeiss Axiovert 200 M
microscope.
Flow Adhesion Assay
Trout blood was drawn into sodium heparin (100 U/ml). Glass
capillary tubes (Camlab, Cambridge, UK) were coated with
matrix proteins for 1 hr at room temperature followed by blocking
with 5 mg/ml of heat-inactivated BSA in PBS for 1 hr at room
temperature, and then mounted on the stage of an inverted
microscope (DM IRB; Leica). Anticoagulated whole blood was
pre-incubated with the fluorescent dye DiOC6 (3,39-dihexylox-
acarbocyanine iodide –2 mM) for 10 min before perfusion through
the chamber at room temperature for 10 min. The thrombocytes
were then washed with modified-Tyrodes buffer followed by
imaging using DIC microscopy on a Zeiss Axiovert 200 M
microscope.
Western Blotting
Zebrafish larvae were lyophilised 48 hrs following injection and
subsequently lysed in RIPA buffer with mechanical crushing to
fully dissolve proteins. The equivalent of 4 larvae per well were
separated by SDS-PAGE, electro-transferred, and western blotted.
Transfected DT40 cells were lysed in RIPA buffer. 106 cells per
well were separated by SDS-PAGE, electro-transferred, and
western blotted.
Cell Culture and Transfection
DT40 chicken B-cells were grown in RPMI supplemented with
10% foetal bovine serum, 1% chicken serum, 100 U/ml penicillin,
100 mg/ml streptomycin, 50 mM b-mercaptoethanol and 20 mM
GlutaMAX. Cells were transfected in 400 ml of serum-free media
by electroporation using a GenePulser II (Bio-Rad, Hertfordshire,
UK) set at 350 V and 500 mF. Cells were transfected as described
above with either 10 mg of the indicated G6fL constructs, or with
2 mg of GPVI plus 2 mg of FcRc, or with an appropriated empty
vector control (Mock) and all cells with an additional 15 mg of the
luciferase reporter construct [13,14]. Twenty hours after transfec-
tion, live cells were counted by trypan blue exclusion. Luciferase
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assays were carried out as described previously [15]. Luciferase
activity was measured with a Centro LB 960 microplate
luminometer (Berthold Technologies, Germany).
Zebrafish Knockdowns
Zebrafish (Ekkwell, Gibsonton, FL, USA) were maintained
under standard conditions. An antisense G6fL Vivo-MO (59-
GCT-TGA-TCA-TTT-TTC-CTC-ATG-ATG-C-39) against the
zebrafish G6fL gene and a control Vivo-MO (59-CCT-CTT-
ACC-TCA-GTT-ACA-ATT-TAT-A-39) were produced by Gene-
Tools LLC (Philomath, OR, USA). Adult zebrafish (.3 months)
were anesthetized and approximately 5 ml Vivo-MOs (either the
original solution supplied by the vendor, 0.5 or 0.05 mM diluted
with PBS, pH 7.4) were taken into a 27K G needle such that the
only Vivo-MO solution remained in the needle. For injection, the
needle was placed into the region located between the second and
third body stripes closer to the anal pore and at right angles to the
location of the inferior vena cava. It was then gently inserted into
the vessel and the contents immediately injected [16]. Zebrafish
larvae (3 days post fertilisation (dpf)) were injected with 5–10 nl
Vivo-MO with glass pulled needles and microinjected intrave-
nously using a Nanoject II (Drummond, Broomall, PA, USA).
Zebrafish Blood Sample Preparation and Aggregation
48 hrs post injection blood collection was performed by gently
poking the lateral surface of the fish body where the caudal artery
and the caudal vein anastomose with a needle. A micropipette set
was used for collecting 1 mL blood welling out from the vessel.
This 1 ml blood was immediately dispensed into a tube containing
1 ml of 3.8% sodium citrate in PBS. Thrombocyte aggregation was
measured by adding 1 ml of citrated blood to 8 ml of 0.63% sodium
citrate in PBS and either 1 ml ADP (200 mM) or collagen (1 mg/
ml) in a conical well of a micro-titre plate. The plate was tilted
manually every 5 min for 1–1.5 hrs at 25uC to determine the time
taken to stop the flow of blood down the walls of the well, i.e. time
taken for thrombocyte aggregation [7].
Laser-induced Injury and Time to Occlusion Analysis
48 hrs following injection zebrafish larvae that showed normal
blood circulation (late phenotype) were placed in agarose blocks
and a pulsed nitrogen laser beam pumped through coumarin 440
dye (Micro Point Laser system, Photonic Instrument, St Charles,
IL, USA) was used to injure vessels around 5–7 somites from the
anal pore to measure time to occlusion as reported previously [17].
Time to occlusion was recorded up to 2 min after injury.
Statistical Analysis
Where applicable, data is expressed as mean 6 standard error.
Statistical analysis was carried out using unpaired Student’s t-tests.
Significance was taken P,0.05.
Results
Collagen Activates Trout Thrombocytes through a Src
Kinase-dependent Pathway
We used blood from rainbow trout to provide a sufficient
sample of blood for investigation of thrombocyte activation by
collagen using whole blood impedance aggregometry (Multiplate),
a method that is routinely used in the investigation of human
platelets. Trout were one of the species of fish used in the initial
identification of G6fL on thrombocytes and have previously been
shown to be responsive to collagen, whereas leukocytes and
erythrocytes are unresponsive to collagen [2,9]. We were unable to
investigate activation of thrombocytes using light transmission
aggregometry as there is no straightforward way to separate
thrombocytes from other blood cells due to their similar size.
Collagen stimulates aggregation of trout thrombocytes at room
temperature (Figure 1), which is approaching the upper temper-
ature for trout. The response was similar to that in human platelets
[18], although the time course was noticeably slower. The
response to 30 mg/ml collagen was faster than that to 10 mg/ml
indicating a similar concentration-response relationship to that
seen in human platelets. Aggregation was inhibited by the Src
kinase inhibitor dasatinib (5 mM) which is effective in whole blood
in contrast to many other Src family kinase inhibitors [19]. This
demonstrates that collagen stimulates aggregation rather than
agglutination.
Trout Thrombocytes Adhere to Collagen
In trout blood, only thrombocytes bind to collagen [2] and thus
they can be readily identified from other blood cells. Under static
conditions, trout thrombocytes underwent adhesion and lamelli-
podia formation on collagen and also on fibrinogen-coated
surfaces (Figure 2A). In both cases, spreading, but not adhesion,
was completely inhibited by dasatinib (5 mM) consistent with a Src
kinase mediated activation event. Furthermore, single thrombo-
cytes were able to adhere and spread on collagen at shear rates
ranging from 100–1000 s21 (Figure 2B). In some instances,
clusters of cells could be seen, although the number of cells in
each cluster was small and they were present as a monolayer in
contrast to the three dimensional aggregates observed in
mammalian platelets under flow. The majority of the adherent
cells in the clusters had formed lamellipodia which were inhibited
in the presence of dasatinib. These results show that thrombocytes
are able to adhere and spread on collagen under static and flow
conditions, and that activation is blocked by Src family kinase
inhibition. This result is similar to that seen in mammalian
platelets where adhesion to collagen is not dependent on
intracellular signalling as it is mediated by GPIb and a2b1 [20],
but signalling through GPVI is required for spreading and
aggregation.
G6fL Responds to Collagen through an ITAM in a Src
Dependent Manner
The observation that collagen activates thrombocytes through a
Src dependent pathway led us to search for a functional equivalent
Figure 1. Trout thrombocytes aggregate to collagen in a Src
dependent manner. Anticoagulated whole blood from rainbow trout
was diluted 1:1 with normal saline (0.9%) and stirred for 3 min at room
temperature in a Multiplate mini-cuvette. Dasatinib (5 mM) or DMSO
vehicle control was pre-incubated at room temperature for 1 min
followed by addition of collagen, 30 or 10 mg/ml, and aggregation was
monitored for 12 min at room temperature. Aggregation was measured
in arbitrary impedance units (AU).
doi:10.1371/journal.pone.0052622.g001
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to the mammalian collagen receptor GPVI which is expressed in
thrombocytes. The key signalling motif in the GPVI/FcR c-chain
complex is an ITAM, which has a conserved sequence of Yxx(L/
I)x6–12Yxx(L/I), and initiates signalling through Src and Syk family
kinases. A novel ITAM-containing receptor, G6fL, has recently
been described on thrombocytes in teleost fish, and additionally on
Figure 2. Trout thrombocytes adhere to and spread on collagen in a Src dependent manner. A) Trout blood was diluted by a factor of
100 to reduce the number of cells, and then allowed to adhere to either collagen or fibrinogen coated coverslips for 90 min at room temperature,
either in the presence of 20 mM dasatinib or DMSO vehicle control. B) Anticoagulated whole blood was flowed through collagen coated glass
capillary tubes at a range of shear rates (i) or at 100 s21 for inhibitor studies (ii). Blood was pre-treated with either 20 mM dasatinib or DMSO vehicle
control.
doi:10.1371/journal.pone.0052622.g002
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the erythrocytes of crucian carp, although its function is not known
[9]. To investigate whether G6fL is a receptor for collagen, we
used an NFAT-luciferase reporter assay that has been previously
used to monitor activation of GPVI by collagen [21]. Zebrafish
G6fL was cloned into an expression vector, and subsequently co-
transfected into chicken DT40 B-cells along with an NFAT-
luciferase reporter construct. Cells transfected with GPVI and FcR
c-chain expression vectors were used as a positive control. Six
hours post stimulation luciferase activity was measured as a
readout of receptor activation. Collagen (10 mg/ml) stimulated a
robust signal in the GPVI/FcR c-chain transfected cells, which
was blocked by the Src kinase inhibitor PP2 (20 mM) (Figure S1),
as previously reported [13]. Strikingly, collagen also stimulated a
marked increase in luciferase activity in G6fL transfected cells
compared to mock transfected cells (Figure 3A) and this response
was again blocked by PP2, as expected for an ITAM signalling
mechanism.
We used site-directed mutagenesis to determine the signalling
motif that underlies activation. G6fL has two distinct signalling
motifs, namely a Grb2 binding site, YxN (Y499) and an ITAM
with tyrosines at Y515 and Y527. Mutation of either of the
conserved ITAM tyrosines to phenylalanine abrogated signalling
to collagen (Figure 3B) thereby demonstrating that both tyrosines
are required for signalling, consistent with an ITAM signalling
pathway [11]. In contrast, mutation of the conserved tyrosine in
the Grb2 binding site (Y499F) had no significant effect on the
NFAT-reporter assay demonstrating that this tyrosine is not
required for activation. These data demonstrate that G6fL
requires an ITAM for signalling in response to collagen.
Activation of GPVI by collagen is mediated through a repeat
glycine-proline-hydroxyproline (GPO) motif and synthetic triple
helical peptides which contain this motif, known as collagen
related peptides (CRP), are powerful activators of the Ig receptor
(Figure S1) [22]. However, CRP (3 mg/ml) had no effect on G6fL-
transfected cells demonstrating that collagen induces activation
through a distinct collagen recognition sequence (Figure 3A).
Consistent with this, CRP was unable to cause aggregation of trout
thrombocytes (not shown) providing further evidence that G6fL
recognising a distinct collagen motif. Thus, the motif in collagen
for activation of G6fL is distinct to that for GPVI. The snake
venom toxin convulxin, which also induces powerful activation of
GPVI, also had no effect on G6fL-transfected cells (not shown) as
anticipated given that they are encoded by distinct genes.
G6fL is Required for Haemostasis in Zebrafish
We used a Vivo-morpholino (MO) to knock-down G6fL levels
in vivo in zebrafish to investigate a possible role for the receptor in
the activation of thrombocytes and in haemostasis. A specific
antibody to G6fL was raised and shown to detect a band at the
predicted molecular weight of 59 kDa and this band was absent in
the MO-treated larvae revealing a high degree of knock-down
(Figure 4A). Equal loading was confirmed by reprobing the
samples for actin. The ability of collagen to stimulate aggregation
of thrombocytes in whole blood from zebrafish was measured
using a plate-tilt assay, which measures the time taken for a drop of
blood to aggregate following the addition of an agonist. The time
to aggregation (TTA) by collagen in this assay is increased from
less than 2 min in control MO-treated larvae to over 30 min in the
G6fL MO-treated larvae, consistent with a critical role of G6fL in
mediating thrombocyte activation (Figure 4B). In comparison, the
time to aggregation in response to ADP was not altered. It was
noted that the blood cell counts were not affected by the knock-
down (not shown). These results confirm that G6fL is a collagen
receptor on thrombocytes and that it plays a critical role in
mediating thrombocyte activation by the matrix protein.
We used a laser injury assay to investigate the role of G6fL in
thrombus formation in vivo in both arteries and veins using MO-
treated larvae. We found that the G6fL MO-treated larvae took
longer to occlude their veins compared to controls (Figure 4C) and
that they were unable to occlude their arteries within the 120 sec
experimental window (Figure 4D). This result confirms a critical
role for G6fL in haemostasis in zebrafish.
Discussion
In this study we have sought to understand the molecular
mechanism of activation of fish thrombocytes by collagen.
Zebrafish, a member of the teleost family, is an increasingly used
model organism for mammalian haemostasis due to the speed and
inexpensive nature of their use and genetic manipulation via
morpholino technology. There are broad similarities which make
this comparison possible to mammalian haemostasis such as the
observation that thrombocytes will occlude vessels in response to
an injury and that they have many orthologs of mammalian
receptors. However, there are gaps in our understanding of fish
thrombocytes, including the lack of a GPVI ortholog, although
they do express an ortholog of the second mammalian collagen
receptor, the integrin a2b1 complex [9]. The question therefore is
whether this is sufficient to mediate platelet adhesion and
activation by collagen or whether fish thrombocytes express a
second receptor which mediates powerful activation, as is the case
in mammalian platelets.
Here, we have shown that trout thrombocytes will respond to
collagen in analogous ways to mammalian platelets i.e. via
spreading and aggregation, and that this response is mediated by
a Src family kinase. This is a new finding as the majority of the
current literature on fish thrombocytes focuses on zebrafish, from
which only tiny amount of blood can be removed for analysis. The
collagen-binding integrin a2b1 has been reported at the gene level
in teleost fish, and the integrin is known to signal weakly through
Src in mammalian platelets although on its own this is insufficient
to mediate platelet activation [20]. This raises the question as to
whether activation of thrombocytes in fish is mediated solely
through integrin a2b1 or whether they express a second activation
receptor for collagen bearing in mind the absence of an ortholog of
GPVI.
In the present study, we show that the novel ITAM-containing
receptor G6fL, which has previously been shown to be expressed
at the mRNA level in a number of teleost fish [9], functions as a
collagen receptor in a cell line reporter assay and in zebrafish
thrombocytes. G6fL has a number of similarities to the mamma-
lian collagen receptor, the GPVI/FcR c-chain complex, including
the presence of extracellular Ig domains (four in the case of G6fL
compared with 2 for GPVI) and a cytosolic ITAM which is similar
to that on FcR c-chain. In addition, it has sequence similarities to
the Ig membrane protein G6f which is expressed on mammalian
platelets, including the presence of a cytosolic Grb2-binding
sequence, YxN [9,23].
We have shown that G6fL signals in response to collagen
through a Src kinase dependent pathway that is critically
dependent on the conserved tyrosines in its ITAM sequence but
is independent of the tyrosine in the Grb2-binding sequence. The
collagen sequence underlying activation of G6fL is distinct from
that of GPVI in that it is unresponsive to CRP, which is a powerful
ligand of the mammalian receptor. This suggests that although
GPVI and G6fL are functionally equivalent in regard to activation
of platelets/thrombocytes, they should not be considered as
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homologs, consistent with their structural differences and genomic
locations [9]. This is an example of convergent evolution of the use
of an ITAM to rapidly activate thrombocytes/platelets upon
binding to collagen.
Definitive evidence that G6fL is a physiologically relevant
collagen receptor mediating thrombocyte activation was achieved
using an in vivo morpholino knock down approach in zebrafish.
The ex vivo activation of platelets by collagen was markedly
reduced following the knock-down of G6fL, leaving the response
to ADP unaffected, and larvae were unable to occlude their
arteries in a laser induced injury, while the response in the venous
system was significantly delayed. While there is no direct evidence
that the laser injury model exposes collagen, these results give
strong indirect evidence that collagen is exposed as the result is
reminiscent of that with GPVI or FcR c-chain-deficient mice,
which have abrogated platelet activation and marked reduction in
thrombus formation, the extent of which is dependent on the
in vivo assay injury [24,25,26]. However, we cannot rule out the
possibility that although collagen is demonstrated here to be an
agonist for G6fL, there may be other agonists in vivo which
mediate thrombus formation.
Figure 3. G6fL responds to collagen in a cell line assay through its ITAM. DT40 cells were transfected with wild type zebrafish G6fL (A) or
with point mutants of G6fL (Y499F, Y515F and Y527F) (B) and stimulated with either collagen (10 mg/ml) or CRP (3 mg/ml). Where stated, cells were
pre-incubated with 20 mM PP2. 6 hrs following stimulation, cells were lysed and luciferase activity was measured as a readout of signalling. Data is
expressed as fold over basal (dotted line). Statistical significance was calculated with a Student’s t-test (*P.0.05, ***P.0.005). Similar levels of
expression of all G6fL constructs was confirmed by western blotting (not shown).
doi:10.1371/journal.pone.0052622.g003
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G6fL is named after its mammalian ortholog G6f, although
there are a significant number of differences between the two
proteins including the reduced number of Ig domains and the
absence of an ITAM in the mammalian protein. Furthermore, G6f
does not appear to be a functional collagen receptor despite
undergoing tyrosine phosphorylation following collagen or CRP
treatment, as it is unable to support adhesion of transfected cells to
a collagen surface or allow signalling to collagen of transfected cells
[23]. The most striking similarities between the two proteins is the
presence of the cytoplasmic Grb2-binding motif which suggests a
novel pathway of regulation of Grb2-effector proteins including
p42/44 MAP kinases, which in mammals play a critical role in
platelet formation in and are implicated in the regulation of several
platelet responses, including phosphorylation of cytosolic phos-
pholipase A2 under certain conditions [27]. We hypothesise that if
the mammalian receptor plays a signalling role in platelets it is
either downstream of either a novel agonist or downstream of the
collagen receptor GPVI.
In summary, in the present study, we have demonstrated the
presence of a novel signalling receptor for collagen in teleost fish,
G6fL, which plays an analogous role to mammalian GPVI. The
structural features and gene location of G6fL and GPVI suggests
that they are unlikely to be orthologs and it is therefore possible
that these disparate receptors independently evolved to respond to
collagen and signal through an ITAM allowing the rapid signalling
required for thrombocyte/platelet activation and rapid haemosta-
sis, an example of convergent evolution. Furthermore, as the
mammalian ortholog of G6fL appears to not be a collagen
receptor, this demonstrates divergent evolution.
Supporting Information
Figure S1 GPVI responds to collagen and CRP in a cell
line assay. DT40 cells were transfected with GPVI/FcRc and
stimulated with either collagen (10 mg/ml) or CRP (3 mg/ml).
Where stated, cells were pre-incubated with 20 mM PP2. 6 hrs
following stimulation, cells were lysed and luciferase activity was
measured as a readout of signalling. Data is expressed as fold over
basal (dotted line). Statistical significance was calculated with a
Student’s t-test (*P.0.05, **P.0.01).
(TIF)
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Figure 4. Zebrafish G6fL is required for haemostasis. A) A novel a-zebrafish G6fL antibody was used to determine knock-down of G6fL in
morpholino (MO) treated larvae. 48 hrs post injection, 3 dpf larvae were lyophilised and lysed. Proteins were separated by SDS-PAGE and Western
blotted with the antibody. The membrane was subsequently stripped and reprobed with an a-actin antibody to confirm equal loading. B) Control
and G6fL MO treated adult fish were bled, and the blood used for a plate tilt aggregation assay. Time to aggregation (TTA) was measured following
addition of either ADP (20 mM) or collagen (100 mg/ml). C) Control and G6fL MO treated larvae were immobilised on a microscope stage and then
injured with a laser in the vessel wall of either veins or arteries (D). Time to occlusion (TTO) of vessels was measured for up to 2 min at which time the
experiment was ceased. Statistical significance was calculated with a Student’s t-test (*P.0.05).
doi:10.1371/journal.pone.0052622.g004
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